Histone deacetylase inhibitors improve the replication of oncolytic herpes simplex virus in breast cancer cells

HIGHLIGHTS

  • who: James J. Cody et al. from the Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America, Department of Neurosurgery, University of Alabama have published the research: Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells, in the Journal: PLOS ONE | www.plosone.org of March/20,/2014
  • what: Because many of these inhibitors have not been tested in the cell lines used in this study the authors first determined LD50 values for each inhibitor. The safety of this approach has been established for . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?